Bozena Konopka

Summary

Affiliation: Institute of Oncology
Country: Poland

Publications

  1. ncbi request reprint The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma
    Bozena Konopka
    Endocrinology Department, Maria Sklodowska Curie Memorial Cancer Center, 5 WK Roentgen Street, 02 781, Warsaw, Poland
    J Cancer Res Clin Oncol 130:114-21. 2004
  2. ncbi request reprint Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations
    Bozena Konopka
    Endocrinology Department, The Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, 5 W K Roentgen Street, 02 781 Warsaw, Poland
    J Cancer Res Clin Oncol 133:361-71. 2007
  3. doi request reprint PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors
    Bozena Konopka
    Endocrinology Department, The Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, 5 W K Roentgen Street, 02 781 Warsaw, Poland
    Hum Pathol 42:1710-9. 2011
  4. ncbi request reprint Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias
    Bozena Konopka
    Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Endocrinology Department, 5 W K Roentgen, 02 781 Warsaw, Poland
    Cancer Lett 178:43-51. 2002
  5. ncbi request reprint TP53 mutations in endometrial cancers: relation to PTEN gene defects
    Aneta Janiec-Jankowska
    Endocrinology Department, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
    Int J Gynecol Cancer 20:196-202. 2010

Detail Information

Publications5

  1. ncbi request reprint The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma
    Bozena Konopka
    Endocrinology Department, Maria Sklodowska Curie Memorial Cancer Center, 5 WK Roentgen Street, 02 781, Warsaw, Poland
    J Cancer Res Clin Oncol 130:114-21. 2004
    ..To evaluate the frequency of ERBB2, INT2 and CMYC oncogene amplifications and their coexistence with PTEN gene mutations in endometrial carcinomas...
  2. ncbi request reprint Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations
    Bozena Konopka
    Endocrinology Department, The Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, 5 W K Roentgen Street, 02 781 Warsaw, Poland
    J Cancer Res Clin Oncol 133:361-71. 2007
    ....
  3. doi request reprint PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors
    Bozena Konopka
    Endocrinology Department, The Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, 5 W K Roentgen Street, 02 781 Warsaw, Poland
    Hum Pathol 42:1710-9. 2011
    ..Moreover, for the first time, a possible role of PIK3CA amplification in initiation and progression of endometrial carcinomas in older women is suggested, but this preliminary suggestion requires further research...
  4. ncbi request reprint Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias
    Bozena Konopka
    Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Endocrinology Department, 5 W K Roentgen, 02 781 Warsaw, Poland
    Cancer Lett 178:43-51. 2002
    ..2393, alpha=0.0071). In conclusion, our data support the view that PTEN gene mutations are frequent events involved in development of endometrial carcinomas in women...
  5. ncbi request reprint TP53 mutations in endometrial cancers: relation to PTEN gene defects
    Aneta Janiec-Jankowska
    Endocrinology Department, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland
    Int J Gynecol Cancer 20:196-202. 2010
    ..Besides that, the correlation was studied between the detected defects and clinicohistopathological characteristics of the studied endometrial cancers...